ABT-702 dihydrochloride is primarily used in scientific research as a potent and selective inhibitor of adenosine kinase, an enzyme involved in regulating adenosine levels in the body. By inhibiting this enzyme, ABT-702 increases extracellular adenosine concentrations, which can modulate neuronal activity and reduce inflammation. It is widely used in studies related to pain management, particularly neuropathic and inflammatory pain, due to adenosine’s role in pain signaling pathways. Researchers also explore its potential in neurological disorders such as epilepsy and neurodegenerative diseases, where adenosine has neuroprotective effects. Additionally, it serves as a pharmacological tool to investigate the adenosinergic system in cellular and animal models, helping to elucidate the therapeutic potential of targeting adenosine metabolism.